AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34

Authors: van Dam, M Stalenhoef, AFH Wittekoek, J Trip, MD Prins, MH Kastelein, JJP
Citation: M. Van Dam et al., Efficacy of concentrated n-3 fatty acids in hypertriglyceridaemia - A comparison with gemfibrozil, CLIN DRUG I, 21(3), 2001, pp. 175-181

Authors: Stalenhoef, AFH Hectors, M Demacker, PNM
Citation: Afh. Stalenhoef et al., Effect of plant sterol-enriched margarine on plasma lipids and sterols in subjects heterozygous for phytosterolaemia, J INTERN M, 249(2), 2001, pp. 163-166

Authors: Bredie, SJH Bosch, FH Demacker, PNM Stalenhoef, AFH van Leusen, R
Citation: Sjh. Bredie et al., Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism, PERIT DIA I, 21(3), 2001, pp. 275-281

Authors: van Tits, LJH de Waart, F Hak-Lemmers, HLM van Heijst, P de Graaf, J Demacker, PNM Stalenhoef, AFH
Citation: Ljh. Van Tits et al., Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers, FREE RAD B, 30(10), 2001, pp. 1122-1129

Authors: Illingworth, RD Crouse, JR Hunninghake, DB Davidson, MH Escobar, ID Stalenhoef, AFH Paragh, G Ma, PTS Liu, M Melino, MR O'Grady, L Mercuri, M Mitchel, YB
Citation: Rd. Illingworth et al., A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial, CURR MED R, 17(1), 2001, pp. 43-50

Authors: De Waart, FG Sehouten, EG Stalenhoef, AFH Kok, FJ
Citation: Fg. De Waart et al., Serum carotenoids, alpha-tocopherol and mortality risk in a prospective study among Dutch elderly, INT J EPID, 30(1), 2001, pp. 136-143

Authors: Smilde, TJ van Wissen, S Wollersheim, H Kastelein, JJP Stalenhoef, AFH
Citation: Tj. Smilde et al., Genetic and metabolic factors predicting risk of cardiovascular disease infamilial hypercholesterolemia, NETH J MED, 59(4), 2001, pp. 184-195

Authors: Smilde, TJ van Wissen, S Kastelein, JJP Stalenhoef, AFH
Citation: Tj. Smilde et al., Measurement of atherosclerosis progression - Reply, LANCET, 358(9278), 2001, pp. 329-329

Authors: Smilde, TJ van Wissen, S Wollersheim, H Trip, MD Kastelein, JJP Stalenhoef, AFH
Citation: Tj. Smilde et al., Effect of aggressive versus conventional lipid lowering on atherosclerosisprogression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial, LANCET, 357(9256), 2001, pp. 577-581

Authors: de Waart, FG Kok, FJ Smilde, TJ Hijmans, A Wollersheim, H Stalenhoef, AFH
Citation: Fg. De Waart et al., Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers, ATHEROSCLER, 158(1), 2001, pp. 227-231

Authors: Lu, KM Lee, MH Hazard, S Brooks-Wilson, A Hidaka, H Kojima, H Ose, L Stalenhoef, AFH Mietinnen, T Bjorkhem, I Bruckert, E Pandya, A Brewer, HB Salen, G Dean, M Srivastava, A Patel, SB
Citation: Km. Lu et al., Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively, AM J HU GEN, 69(2), 2001, pp. 278-290

Authors: de Roos, B Caslake, MJ Stalenhoef, AFH Bedford, D Demacker, PNM Katan, MB Packard, CJ
Citation: B. De Roos et al., The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects, AM J CLIN N, 73(1), 2001, pp. 45-52

Authors: Smilde, TJ Trip, MD Wollersheim, H van Wissen, S Kastelein, JJP Stalenhoef, AFH
Citation: Tj. Smilde et al., Rationale, design and baseline characteristics of a clinical trial comparing the effects of robust vs conventional cholesterol lowering and intima media thickness in patients with familial hypercholesterolaemia - The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study, CLIN DRUG I, 20(2), 2000, pp. 67-79

Authors: de Waart, FG Smilde, T Wollersheim, H Stalenhoef, AFH Kok, FJ
Citation: Fg. De Waart et al., Smoking characteristics, antioxidant vitamins, and carotid artery wall thickness among life-long smokers, J CLIN EPID, 53(7), 2000, pp. 707-714

Authors: Netea, MG Dinarello, CA Kullberg, BJ Jansen, T Jacobs, L Stalenhoef, AFH Van der Meer, JWM
Citation: Mg. Netea et al., Oxidation of low-density lipoproteins by acellular components of Chlamydiapneumoniae, J INFEC DIS, 181(5), 2000, pp. 1868-1869

Authors: Demacker, PNM Veerkamp, MJ Bredie, SJH Marcovina, SM de Graaf, J Stalenhoef, AFH
Citation: Pnm. Demacker et al., Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia, ATHEROSCLER, 153(2), 2000, pp. 483-490

Authors: Stalenhoef, AFH de Graaf, J Wittekoek, ME Bredie, SJH Demacker, PNM Kastelein, JJP
Citation: Afh. Stalenhoef et al., The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia, ATHEROSCLER, 153(1), 2000, pp. 129-138

Authors: Kroon, AA van't Hof, MA Demacker, PNM Stalenhoef, AFH
Citation: Aa. Kroon et al., The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels, ATHEROSCLER, 152(2), 2000, pp. 519-526

Authors: Hoffer, MJV Snieder, H Bredie, SJH Demacker, PNM Kastelein, JJP Frants, RR Stalenhoef, AFH
Citation: Mjv. Hoffer et al., The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia, ATHEROSCLER, 151(2), 2000, pp. 443-450

Authors: Demacker, PNM Hectors, MPC Stalenhoef, AFH
Citation: Pnm. Demacker et al., Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: a new physiological concept, ATHEROSCLER, 149(1), 2000, pp. 169-180

Authors: Netea, MG Selzman, CH Kullberg, BJ Galama, JMD Weinberg, A Stalenhoef, AFH Van der Meer, JWM Dinarello, CA
Citation: Mg. Netea et al., Acellular components of Chlamydia pneumoniae stimulate cytokine productionin human blood mononuclear cells, EUR J IMMUN, 30(2), 2000, pp. 541-549

Authors: de Bont, N Netea, MG Demacker, PNM Kullberg, BJ van der Meer, JWM Stalenhoef, AFH
Citation: N. De Bont et al., Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae, EUR J CL IN, 30(9), 2000, pp. 818-822

Authors: Smilde, TJ van den Berkmortel, FW Wollersheim, H van Langen, H Kastelein, JJ Stalenhoef, AFH
Citation: Tj. Smilde et al., The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia, EUR J CL IN, 30(6), 2000, pp. 473-480

Authors: van den Berkmortel, FWPJ Demacker, PNM Wollersheim, H Thien, T Stalenhoef, AFH
Citation: Fwpj. Van Den Berkmortel et al., Smoking or its cessation does not alter the susceptibility to in vitro LDLoxidation, EUR J CL IN, 30(11), 2000, pp. 972-979

Authors: de Graaf, J Hoffer, MJV Stuyt, PMJ Frants, RR Stalenhoef, AFH
Citation: J. De Graaf et al., Familial chylomicronemia caused by a novel type of mutation in the APOE-CI-CIV-CII gene cluster encompassing both the APOCII gene and the first APOCIV gene mutation: APOCII-CIVNijmegen, BIOC BIOP R, 273(3), 2000, pp. 1084-1087
Risultati: 1-25 | 26-34